Rapid blood test using GFAP to tell hemorrhagic vs ischemic stroke
Official title: Biomarkers Based EArly Diagnosis of STroke Subtype Cohort, Bio-EAST
Run by Shanghai East Hospital · NCT07003477 · Data updated 2026-11-12
This project will test whether a quick blood test for GFAP can tell if adults with suspected stroke have bleeding in the brain when they arrive within three hours of symptom onset.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 527 (estimated) |
| Sponsor | Shanghai East Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | June 12, 2025 |
| Main results expected | August 30, 2028 |
| Study ends | November 30, 2028 |
| Registry record updated | January 21, 2026 |
| Trial ID | NCT07003477 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who arrive with suspected stroke (FAST score ≥2 including limb weakness) within three hours of symptom onset are ideal candidates for this project.
✕Probably not a fit
Patients in coma, with severe comorbidities that limit daily living, recent head trauma, seizure-onset strokes, or very low blood glucose are excluded and may not benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort will enroll adults with suspected stroke who present within three hours and collect peripheral blood to measure GFAP and other biomarkers. The project partners hospitals with industry to develop and validate a rapid diagnostic workflow aimed at pre-hospital and emergency use. Results will be compared to clinical imaging to determine how well the biomarker distinguishes intracerebral hemorrhage from ischemic stroke. The goal is to produce data that could support faster, guided treatment decisions in the ambulance or emergency department.
Why it matters
Potential benefit: If successful, the test could allow clinicians to identify intracerebral hemorrhage quickly and start appropriate treatments sooner, potentially improving outcomes.
How similar studies have gone: Prior clinical work has shown GFAP is highly specific for intracerebral hemorrhage and trials like INTERACT4 demonstrated benefit of very early blood-pressure lowering, but deploying GFAP as a rapid pre-hospital diagnostic tool is a newer application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years old; 2. Suspected stroke at emergency department arrival (FAST score ≥ 2 points, must include limb weakness); 3. Time of stroke symptom onset/last known normal within 3 hours. Exclusion Criteria: 1. Coma - no response to tactile or verbal stimuli; 2. Severe comorbidities (such as tumors, severe COPD, severe heart failure, requiring assistance with daily living \[unable to walk independently\]); 3. History of epilepsy or onset with seizure; 4. Recent history of head trauma (\< 7 days); 5. Blood glucose \< 2.8 mmol/L.
Where it's running
-
Shanghai East Hospital
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Gang Li
- Email: ligang@tongji.edu.cn
- Phone: +86 136 2169 1786
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.